MDXG Q2 2017 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$666M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$76M+33.3% YoY

Gross Profit

$68M88.7% margin

Operating Income

$7M9.4% margin

Net Income

$8M10.6% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

+5.2%

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

$12M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$200M

Total Liabilities

$53M

Stockholders' Equity

$147M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$76M	$57M	+33.3%
Gross Profit	$68M	$50M	+35.7%
Operating Income	$7M	$4M	+102.6%
Net Income	$8M	$2M	+308.6%